{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:27:54Z","timestamp":1781555274270,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-022-01978-1","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T11:03:12Z","timestamp":1670670192000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Evaluation of the effects of empagliflozin on acute lung injury in rat intestinal ischemia\u2013reperfusion model"],"prefix":"10.1007","volume":"46","author":[{"given":"P.","family":"Gokbulut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kuskonmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Yumusak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Erel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Nural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Culha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"issue":"2","key":"1978_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00000658-199208000-00002","volume":"216","author":"EA Deitch","year":"1992","unstructured":"Deitch EA (1992) Multiple organ failure pathophysiology and potential future therapy. Ann Surg 216(2):117\u2013134. https:\/\/doi.org\/10.1097\/00000658-199208000-00002. (PMID: 1503516; PMCID: PMC1242583)","journal-title":"Ann Surg"},{"issue":"7","key":"1978_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/0748233711430984","volume":"29","author":"A Guzel","year":"2013","unstructured":"Guzel A, Kanter M, Guzel A (2013) Protective effect of curcumin on acute lung injury induced by intestinal ischaemia\/reperfusion. Toxicol Ind Health 29(7):633\u2013642. https:\/\/doi.org\/10.1177\/0748233711430984. (Epub 2012 Jan 17. Erratum in: Toxicol Ind Health. 2013 Nov;29(10):969. PMID: 22252860)","journal-title":"Toxicol Ind Health"},{"issue":"3","key":"1978_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MOT.0000000000000304","volume":"21","author":"VE Laubach","year":"2016","unstructured":"Laubach VE, Sharma AK (2016) Mechanisms of lung ischemia\u2013reperfusion injury. Curr Opin Organ Transpl 21(3):246\u2013252. https:\/\/doi.org\/10.1097\/MOT.0000000000000304. (PMID:26945320;PMCID:PMC4861054)","journal-title":"Curr Opin Organ Transpl"},{"issue":"1\u20132","key":"1978_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/00365513.2017.1422540","volume":"78","author":"B Gulpamuk","year":"2018","unstructured":"Gulpamuk B, Tekin K, Sonmez K (2018) The significance of thiol\/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus. Scand J Clin Lab Invest 78(1\u20132):136\u2013142. https:\/\/doi.org\/10.1080\/00365513.2017.1422540. (Epub 2018 Jan 3. PMID: 29298534)","journal-title":"Scand J Clin Lab Invest"},{"key":"1978_CR5","doi-asserted-by":"publisher","first-page":"590987","DOI":"10.1155\/2015\/590987","volume":"2015","author":"RS Ferrari","year":"2015","unstructured":"Ferrari RS, Andrade CF (2015) Oxidative stress and lung \u0131schemia\u2013reperfusion \u0131njury. Oxid Med Cell Longev 2015:590987. https:\/\/doi.org\/10.1155\/2015\/590987. (Epub 2015 Jun 16. PMID: 26161240; PMCID: PMC4487720)","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"1978_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-6143.2004.00701.x","volume":"5","author":"SM Quadri","year":"2005","unstructured":"Quadri SM, Segall L, de Perrot M (2005) Caspase inhibition improves ischemia\u2013reperfusion injury after lung transplantation. Am J Transpl 5(2):292\u2013299. https:\/\/doi.org\/10.1111\/j.1600-6143.2004.00701.x. (PMID: 15643988)","journal-title":"Am J Transpl"},{"issue":"15","key":"1978_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, EMPEROR-Reduced Trial Investigators (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383(15):1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190. (Epub 2020 Aug 28. PMID: 32865377)","journal-title":"N Engl J Med"},{"key":"1978_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.resp.2019.103316","volume":"273","author":"AM Kabel","year":"2020","unstructured":"Kabel AM, Estfanous RS, Alrobaian MM (2020) Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin induced lung fibrosis. Respir Physiol Neurobiol 273:103316. https:\/\/doi.org\/10.1016\/j.resp.2019.103316. (Epub 2019 Oct 7 PMID: 31600583)","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"1978_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2.PMID:30710997;PMCID:PMC6359811","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M (2019) SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol 18(1):15. https:\/\/doi.org\/10.1186\/s12933-019-0816-2.PMID:30710997;PMCID:PMC6359811","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"1978_CR10","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00210-018-1544-y","volume":"391","author":"NAT Abbas","year":"2018","unstructured":"Abbas NAT, El Salem A, Awad MM (2018) Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression. Naunyn Schmiedebergs Arch Pharmacol 391(12):1347\u20131360. https:\/\/doi.org\/10.1007\/s00210-018-1544-y. (Epub 2018 Aug 8 PMID: 30090949)","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"1978_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3390\/ijms22020818","volume":"22","author":"N Nasiri-Ansari","year":"2021","unstructured":"Nasiri-Ansari N, Nikolopoulou C, Papoutsi K (2021) Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(-\/-) Mice by activating autophagy and reducing ER stress and apoptosis. Int J Mol Sci 22(2):818. https:\/\/doi.org\/10.3390\/ijms22020818. (PMID:33467546;PMCID:PMC7829901)","journal-title":"Int J Mol Sci"},{"issue":"7\u20138","key":"1978_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/s0899-9007(03)00057-1","volume":"19","author":"A Takil","year":"2003","unstructured":"Takil A, Umuro\u011flu T, G\u00f6\u011f\u00fc\u015f YF, Eti Z (2003) Histopathologic effects of lipid content of enteral solutions after pulmonary aspiration in rats. Nutrition 19(7\u20138):666\u2013669. https:\/\/doi.org\/10.1016\/s0899-9007(03)00057-1. (PMID: 12831956)","journal-title":"Nutrition"},{"issue":"18","key":"1978_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.clinbiochem.2014.09.026","volume":"47","author":"O Erel","year":"2014","unstructured":"Erel O, Neselioglu S (2014) A novel and automated assay for thiol\/disulphide homeostasis. Clin Biochem 47(18):326\u2013332. https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.026. (Epub 2014 Oct 7 PMID: 25304913)","journal-title":"Clin Biochem"},{"issue":"4","key":"1978_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0736-4679(00)00255-9","volume":"19","author":"D Bar-Or","year":"2000","unstructured":"Bar-Or D, Lau E, Winkler JV (2000) A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 19(4):311\u2013315. https:\/\/doi.org\/10.1016\/s0736-4679(00)00255-9. (PMID: 11074321)","journal-title":"J Emerg Med"},{"issue":"4","key":"1978_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1164\/rccm.200207-670SO","volume":"167","author":"M de Perrot","year":"2003","unstructured":"de Perrot M, Liu M, Waddell TK, Keshavjee S (2003) Ischemia\u2013reperfusion-induced lung injury. Am J Respir Crit Care Med 167(4):490\u2013511. https:\/\/doi.org\/10.1164\/rccm.200207-670SO. (PMID: 12588712)","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1978_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jss.2012.08.026","volume":"179","author":"LA Forgiarini Jr","year":"2013","unstructured":"Forgiarini LA Jr, Gr\u00fcn G, Kretzmann NA (2013) When is injury potentially reversible in a lung ischemia\u2013reperfusion model? J Surg Res 179(1):168\u2013174. https:\/\/doi.org\/10.1016\/j.jss.2012.08.026. (Epub 2012 Sep 10 PMID: 22989553)","journal-title":"J Surg Res"},{"key":"1978_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106969","volume":"88","author":"F Lin","year":"2020","unstructured":"Lin F, Song C, Zeng Y (2020) Canagliflozin alleviates LPS-induced acute lung injury by modulating alveolar macrophage polarization. Int Immunopharmacol 88:106969. https:\/\/doi.org\/10.1016\/j.intimp.2020.106969. (Epub 2020 Sep 11 PMID: 33182027)","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1978_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5505\/tjtes.2018.82826","volume":"25","author":"ZB Kingir","year":"2019","unstructured":"Kingir ZB, \u00d6zdemir Kural ZN, Cam ME (2019) Effects of dapagliflozin in experimental sepsis model in rats. Ulus Travma Acil Cerrahi Derg 25(3):213\u2013221. https:\/\/doi.org\/10.5505\/tjtes.2018.82826. (PMID: 31135951)","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"issue":"4","key":"1978_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cmet.2019.08.015","volume":"30","author":"DA Hess","year":"2019","unstructured":"Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S (2019) SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus. Cell Metab 30(4):609\u2013613. https:\/\/doi.org\/10.1016\/j.cmet.2019.08.015. (Epub 2019 Aug 30 PMID: 31477497)","journal-title":"Cell Metab"},{"issue":"7","key":"1978_CR20","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3390\/jcm9072030","volume":"9","author":"B Fernandez-Fernandez","year":"2020","unstructured":"Fernandez-Fernandez B, D\u2019Marco L, G\u00f3rriz JL (2020) Exploring sodium glucose co-transporter-2 (SGLT2) inhibitors for organ protection in COVID-19. J Clin Med 9(7):2030. https:\/\/doi.org\/10.3390\/jcm9072030. (PMID:32605278;PMCID:PMC7409231)","journal-title":"J Clin Med"},{"issue":"1","key":"1978_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.32725\/jab.2019.003","volume":"17","author":"MA Abd Elmaaboud","year":"2019","unstructured":"Abd Elmaaboud MA, Kabel AM, Elrashidy M (2019) Pre-treatment with empagliflozin ameliorates cisplatin induced acute kidney injury by suppressing apoptosis. J Appl Biomed 17(1):90. https:\/\/doi.org\/10.32725\/jab.2019.003. (Epub 2019 Feb 6. PMID: 34907751)","journal-title":"J Appl Biomed"},{"issue":"4","key":"1978_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239240","volume":"16","author":"S Kinaneh","year":"2021","unstructured":"Kinaneh S, Knany Y, Khoury EE, Ismael-Badarneh R, Hamoud S, Berger G, Abassi Z, Azzam ZS (2021) Identification, localization and expression of NHE isoforms in the alveolar epithelial cells. PLoS One 16(4):e0239240. https:\/\/doi.org\/10.1371\/journal.pone.0239240. (PMID:33882062;PMCID:PMC8059851)","journal-title":"PLoS ONE"},{"issue":"2","key":"1978_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1086\/680213.PMID:26064449;PMCID:PMC4449235","volume":"5","author":"J Huetsch","year":"2015","unstructured":"Huetsch J, Shimoda LA (2015) Na(+)\/H(+) exchange and hypoxic pulmonary hypertension. Pulm Circ 5(2):228\u2013243. https:\/\/doi.org\/10.1086\/680213.PMID:26064449;PMCID:PMC4449235","journal-title":"Pulm Circ"},{"issue":"5","key":"1978_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266890","volume":"17","author":"D Adams","year":"2022","unstructured":"Adams D, Choi CS, Sayner SL (2022) Pulmonary endothelial cells from different vascular segments exhibit unique recovery from acidification and Na+\/H+ exchanger isoform expression. PLoS One 17(5):e0266890. https:\/\/doi.org\/10.1371\/journal.pone.0266890. (PMID:35503765;PMCID:PMC9064095)","journal-title":"PLoS ONE"},{"issue":"3","key":"1978_CR25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.121.000956","volume":"380","author":"D Huang","year":"2022","unstructured":"Huang D, Ju F, Du L, Liu T, Zuo Y, Abbott GW, Hu Z (2022) Empagliflozin protects against pulmonary ischemia\/reperfusion injury via an extracellular signal-regulated kinases 1 and 2-dependent Mechanism. J Pharmacol Exp Ther 380(3):230\u2013241. https:\/\/doi.org\/10.1124\/jpet.121.000956. (Epub 2021 Dec 10 PMID: 34893552)","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-022-01978-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-022-01978-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T16:10:10Z","timestamp":1681575010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-022-01978-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1007\/s40618-022-01978-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,10]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the ethical standards specified in the 1964 Declaration of Helsinki. Research and publication ethical rules were followed in our study. Our study was approved by the ethics committee of Ankara Training and Research Hospital Animal Experiments Local Ethics Committee, dated 26.07.2021, with a 0066 meeting and 668 decision number.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"In our animal study titled \u2018Evaluation of the effects of empagliflozin on acute lung injury in rat intestinal ischemia\u2013 reperfusion model\u2019, no informed consent is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed constent"}}]}}